ClinicalTrials.Veeva

Menu

The Use of Virtual Reality to Reduce Anxiety and Pain in Perioperative Settings

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Enrolling

Conditions

Perioperative Pain
Perioperative Anxiety

Treatments

Other: Virtual Reality Distraction

Study type

Interventional

Funder types

Other

Identifiers

NCT03744845
17-22021

Details and patient eligibility

About

We will investigate whether the use of Virtual Reality (VR) preoperatively and intraoperatively can help treat pain and anxiety, as measured by patient feedback, vital signs trends, and the amounts of anesthetics, pain medications and anxiolytics used during surgical procedures. The VR intervention will be studied during short hand surgeries normally performed using local anesthesia and sedation.

Full description

Virtual Reality (VR) is a powerful and inexpensive technology that has been effectively used in healthcare settings to treat anxiety and pain, with minimal side effects. In the last two decades, opioid abuse and deaths related to opioids have increased, and opioid naive patients are at increased risk of opioid abuse when opioids are used during their surgical procedures. In addition, anesthetics, anxiolytics and analgesics, namely opioids, have a myriad of side effects that worsen patient experience, and lead to complications and increased costs. There are limited studies on the use of VR in the perioperative setting. Our study is a randomized controlled trial to investigate the use of VR to treat anxiety and pain in perioperative settings. We will recruit 56 patients, 28 in the control group and 28 in the VR group, undergoing short (<2 hrs) hand or upper extremity surgeries under local anesthesia and monitored anesthesia care (MAC). The control group will receive standard anesthetic management and the VR group will be exposed to VR in the preoperative setting and during the surgical procedure, using the clinically validated AppliedVR software. The data collected will included satisfaction questionnaires and pain scores for anxiety/pain pre- and post- procedure, vital signs trends to assess sympathetic response during surgery, and amount of anesthetics used. We hypothesize that the VR group will show decreased anxiety and pain, increased satisfaction, and decreased use of anesthetics during the procedure.

Enrollment

56 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 18 years old or older and less or equal to 75 years old.
  2. ASA physical status I-II.
  3. English speaking.
  4. Undergoing elective surgery with local anesthetic with sedation.
  5. Surgical time less than 2 hours.

Exclusion criteria

  1. ASA physical status III or above.
  2. Allergy to fentanyl, midazolam or propofol.
  3. History of seizure, migraines.
  4. Chronic Pain Syndrome.
  5. Use of high dose opioids or long acting opioids.
  6. Severe anxiety, on daily anxiolytics.
  7. Psychiatric comorbidities that preclude the use of VR.
  8. Physical disabilities that preclude the use of VR technology in a comfortable manner.
  9. Patient refusal.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

56 participants in 2 patient groups

Control group
No Intervention group
Description:
Usual anesthetic care.
Virtual Reality Intervention Group
Experimental group
Description:
Virtual Reality Distraction
Treatment:
Other: Virtual Reality Distraction

Trial contacts and locations

1

Loading...

Central trial contact

Valeria Carcamo-Cavazos, M.D.; Sakura Kinjo, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems